Literature DB >> 8408055

Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells.

A Kosaki1, N J Webster.   

Abstract

We have shown that culturing HepG2 cells in Ham's F-12 medium supplemented with calf serum, dexamethasone, and triiodothyronine causes an increase in the insulin sensitivity and responsiveness for glucose incorporation into glycogen. This correlates with increased expression of the mRNA encoding the B isoform of the insulin receptor. Of all the components in the medium, we found that dexamethasone exerted the greatest effect. Dexamethasone alone could cause both a switch in expression from the A to the B isoform of the insulin receptor and also an increase in insulin sensitivity for both glucose incorporation into glycogen and 2-deoxyglucose transport. In addition, we found that expression of the B isoform of the insulin receptor is developmentally regulated in the 3T3-L1 adipocyte leading to the suggestion that the alternatively spliced B isoform of the insulin receptor may play an important role in signal transduction in insulin target tissues such as liver, fat, and muscle.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408055

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform A.

Authors:  Alaide Morcavallo; Marco Genua; Angela Palummo; Emilia Kletvikova; Jiri Jiracek; Andrzej M Brzozowski; Renato V Iozzo; Antonino Belfiore; Andrea Morrione
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

2.  Effect of dexamethasone on insulin receptor mRNA levels, RNA stability and isotype RNA pattern in U-937 human promonocytic cells.

Authors:  M A Leal; P Aller; C Calle
Journal:  J Endocrinol Invest       Date:  1996-09       Impact factor: 4.256

3.  Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator.

Authors:  H König; H Ponta; P Herrlich
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

4.  Pharmacologic correction of dominant-negative GH1 deficiency causing mutations.

Authors:  Justin S Poling; John A Phillips; Joy D Cogan; Rizwan Hamid
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

5.  Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.

Authors:  F Frasca; G Pandini; P Scalia; L Sciacca; R Mineo; A Costantino; I D Goldfine; A Belfiore; R Vigneri
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

6.  Opposing actions of adrenal androgens and glucocorticoids on alternative splicing of Slo potassium channels in bovine chromaffin cells.

Authors:  Guey-Jen Lai; David P McCobb
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

7.  Nova-1 mediates glucocorticoid-induced inhibition of pre-mRNA splicing of gonadotropin-releasing hormone transcripts.

Authors:  Eonyoung Park; Mi Sun Lee; Sun Mi Baik; Eun Bee Cho; Gi Hoon Son; Jae Young Seong; Kun Ho Lee; Kyungjin Kim
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

8.  SRp20 and CUG-BP1 modulate insulin receptor exon 11 alternative splicing.

Authors:  Supriya Sen; Indrani Talukdar; Nicholas J G Webster
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

9.  Increased expression of low-affinity insulin receptor isoform and insulin/insulin-like growth factor-I hybrid receptors in term placenta from insulin-resistant women with gestational hypertension.

Authors:  H Valensise; Y Y Liu; M Federici; D Lauro; D Dell'anna; C Romanini; G Sesti
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

10.  Hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey.

Authors:  Z Huang; N L Bodkin; H K Ortmeyer; B C Hansen; A R Shuldiner
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.